Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping reviewPsychedelics · 2026-07-26Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study.BJPsych open · 2025-12-15519. PSILOCYBIN ASSISTED PSYCHOTHERAPY FOR OBSESSIVE COMPULSIVE DISORDER, BODY DYSMORPHIC DISORDER, AND ANOREXIA NERVOSA: STUDY PROTOCOLThe international journal of neuropsychopharmacology · 2025-08-01229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIALThe international journal of neuropsychopharmacology · 2025-08-01Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial.Therapeutic advances in psychopharmacology · 2025-01-01Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.BJPsych open · 2023-07-25A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocolEuropean psychiatry: the journal of the Association of European Psychiatrists · 2023-07-19Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?The Australian and New Zealand journal of psychiatry · 2023-07-01The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24Default Mode Network Modulation by Psychedelics: A Systematic Review.The international journal of neuropsychopharmacology · 2023-03-22The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2023-01-01A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.CNS drugs · 2022-10-01The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.Psychiatry research · 2022-07-01Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.CNS drugs · 2022-01-01A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.Journal of clinical psychopharmacology · 2022-01-01Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?Frontiers in psychiatry · 2022-01-01Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.The Australian and New Zealand journal of psychiatry · 2021-12-01Psilocybin-assisted therapy for depression: How do we advance the field?The Australian and New Zealand journal of psychiatry · 2020-03-01